Coloplast AS Class B COLO B

Morningstar Rating
DKK 508.00 +13.90 (2.81%)
View Full Chart

Company Report

Price vs Fair Value

COLO B is trading at a LOCK|LF!T<%J premium.
Price
DKK 494.10
Fair Value
LOCK|w@
Uncertainty
LOCK|CvNgN
1-Star Price
LOCK|mv
5-Star Price
#W>
Economic Moat
LOCK|@!jMy
Capital Allocation
LOCK|B$GtR!f

Bulls Say, Bears Say

Bulls

Coloplast's dominant position in ostomy and continence care is built on decades of innovation and customer relationships that are difficult to replicate and supports both pricing resilience and long-term customer retention.

Bears

With the majority of revenue subject to third-party reimbursement, Coloplast is structurally exposed to healthcare cost containment—most concretely illustrated by the anticipated introduction of Medicare competitive bidding in the US from 2028 onward.

Trading Information

Previous Close Price
DKK 494.10
Day Range
DKK 494.10–508.00
52-Week Range
DKK 369.70–599.40
Bid/Ask
DKK 507.60 / DKK 508.00
Shares Outstanding
225.37M
Market Cap
DKK 114.49B
Volume/Avg
297,381 / 370,887

Key Statistics

Price/Earnings (Normalized)
35.62
Price/Sales
3.85
Dividend Yield (Trailing)
4.65%
Dividend Yield (Forward)
4.65%
Dividend Payment Schedule
May, Dec
Total Yield
4.65%

Company Profile

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
17,213

Competitors

Valuation

Metric
COLO B
BSX
CTEC
Price/Earnings (Normalized)
35.6213.8626.33
Price/Book Value
7.792.504.64
Price/Sales
3.853.102.74
Price/Cash Flow
14.5613.0314.80
Price/Earnings
COLO B
BSX
CTEC

Financial Strength

Metric
COLO B
BSX
CTEC
Quick Ratio
0.410.621.06
Current Ratio
0.741.361.93
Interest Coverage
6.8210.673.34
Quick Ratio
COLO B
BSX
CTEC

Profitability

Metric
COLO B
BSX
CTEC
Return on Assets (Normalized)
11.74%10.68%9.54%
Return on Equity (Normalized)
39.52%19.06%22.72%
Return on Invested Capital (Normalized)
16.18%13.72%13.15%
Return on Assets
COLO B
BSX
CTEC

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|^QwWRxCLOCK|>&%$152B
Becton Dickinson & Co
BDX
LOCK|<g<LOCK|#tS^R$59B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|y^#NlX#LOCK|x#L%&$35B
Alcon Inc
ALC
LOCK|bW?fh#!LOCK|$K<<g$35B
ResMed Inc
RMD
LOCK|C&H$P&xLOCK|d>R%$34B
West Pharmaceutical Services Inc
WST
LOCK|!&ZdpRRFLOCK|Q>$29B
Solventum Corp
SOLV
LOCK|?X^Kw&BLOCK|rB>$15B
Baxter International Inc
BAX
LOCK|V?yLOCK|Z@&Gl$13B
The Cooper Companies Inc
COO
LOCK|#q#cHkLOCK|dLL<$12B
Align Technology Inc
ALGN
LOCK|dGnPLHkLOCK|N<^X?$12B

Sponsor Center